Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Veterinary Molecular Diagnostics Market Snapshot (2023 to 2033)

The global veterinary molecular diagnostics market size is expected to be valued at US$ 194.47 million in 2023, surpassing US$ 377.22 million by 2033. The demand for veterinary molecular diagnostics is projected to grow at a CAGR of 6.84% between 2023 and 2033.

The growth can be attributed to:

  • The rising adoption of multiple testing panels.
  • The growing consolidation in the veterinary diagnostics industry.
  • The growing pet animal population around the globe.
  • Increased animal health spending and advancements in veterinary molecular diagnostics.
  • Developments in the animal farming sector and changing societal attitudes toward pet animals.
  • Increased demand for fast and reliable diagnostic techniques.
  • Molecular diagnostics possess the potential to address this growing demand.

Rising Pet Adoption and Animal Health Expenditure to Become Key Trends in the Veterinary Molecular Diagnostics Industry

As of 2022, more than 61% of the United States population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.

The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions. Also, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.

Untapped Emerging Markets to Accelerate the Adoption of Veterinary Molecular Diagnostics

The emerging economies are expected to become a focal point for the growth of the veterinary diagnostics market. The Asia Pacific, Middle Eastern, and Latin American regions are relatively untapped markets for companies compared to Europe and North America.

Large poultry and dairy animal populations in these emerging markets are expected to drive the growth of the veterinary health market. Currently, the number of veterinarians in emerging markets is on the rise.

Emerging countries like India and China have robust livestock markets. According to the Livestock Production Statistics of India 2018, India is one of the largest milk producers (20.17% of the global production), followed by the United States, China, Brazil, and Pakistan.

Further, many veterinary practices are adopting technologically advanced solutions commonly used by veterinarians in developed economies. Thus, with a surge in the companion animal population, growing demand for veterinary services from the livestock industry, and growing companion animal health expenditure, emerging countries across the Asia Pacific and Latin America are expected to offer significant growth opportunities for the market.

High Cost Associated with the Rising Pet Care to Limit the Market Growth

In the last ten years, pet care costs have increased significantly. According to the APPA 2019 report, veterinary care is the second-highest source of spending in the pet care community. The United States, for example, spent over US$ 18.11 billion on veterinary care in 2018, a growth of 6.1% over the previous year. This is expected to reach US$ 19.98 billion in 2019.

Advanced products and procedures play a significant role in treatments. However, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.

Data Points Key Statistics
Veterinary Molecular Diagnostics Market Value 2023 US$ 194.47 million
Veterinary Molecular Diagnostics Market Projected Value (2033) US$ 377.22 million
Veterinary Molecular Diagnostics Market CAGR (2023 to 2033) 6.84%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Veterinary Molecular Diagnostics Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)

In 2018, the market represented revenue of US$ 127.69 million. From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 7.3%.

During the historical period of 2018 to 2022, the veterinary molecular diagnostics market experienced steady growth due to the increasing prevalence of zoonotic diseases. Including growing awareness among pet owners about animal health, and advancements in molecular diagnostic techniques. In addition, the rising demand for animal-derived food products and the need for early disease diagnosis in livestock have also contributed to the growth of this market.

The global demand for veterinary molecular diagnostics is projected to increase at a CAGR of 6.84% during the forecast period between 2022 and 2033. The market is anticipated to reach a total of US$ 377.22 million in 2033.

Moving forward, the global veterinary molecular diagnostics market is expected to continue its growth trajectory due to the increasing adoption of pets, the growing awareness about animal health, and the rising prevalence of zoonotic diseases. Additionally, the development of novel molecular diagnostic techniques and the emergence of advanced technologies such as next-generation sequencing is also expected to drive market growth.

The market is expected to face challenges such as the high cost associated with molecular diagnostic tests and the lack of skilled professionals in this field. Nonetheless, the increasing prevalence of zoonotic diseases and the rising demand for early disease diagnosis in animals are expected to be the key drivers of market growth.

Comparative View of the Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market:

Attributes Veterinary Molecular Diagnostics Market
CAGR (2023 to 2033) 6.84%
Market Value (2033) US$ 377.22 million
Opportunity Increasing adoption of pets and rising prevalence of zoonotic diseases
Key Trends Development of novel molecular diagnostic techniques and the emergence of advanced technologies such as next-generation sequencing

Viral Molecular Diagnostics Market:

Attributes Viral Molecular Diagnostics Market
CAGR (2023 to 2033) 10%
Market Value (2033) US$ 32.4 billion
Opportunity Growing demand for early diagnosis of viral diseases
Key Trends Increasing use of PCR-based tests for rapid and accurate diagnosis of viral infections

Automated Molecular Diagnostics Testing System Market:

Attributes Automated Molecular Diagnostics Testing System Market
CAGR (2023 to 2033) 5.6%
Market Value (2033) US$ 51 billion
Opportunity Rising demand for high-throughput and automated diagnostic systems
Key Trends Development of compact and user-friendly automated diagnostic systems with advanced features such as AI and data management
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Rising Pet Adoption in the United States to Boost the Market Growth

The veterinary molecular diagnostics market in the United States is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.

In addition, the presence of major players is one of the major factors contributing to the dominance of the country in the global veterinary molecular diagnostics industry. Moreover, rising awareness about animal wellness and increasing efforts by organizations to promote animal welfare activities in the United States are further promoting the growth of the market in the nation.

High Usage of Superior Quality Diagnostics Techniques in Germany

The veterinary molecular diagnostics market in Germany is expected to accumulate a market share of 9.5% in 2023. The regional market is expected to continue to maintain the trend over the forecast period as well.

Germany is the second-most lucrative country in the global veterinary molecular diagnostics industry, behind the US. Increased government backing, high-quality diagnostic procedures, and the number of veterinary diagnostic centers are the major factors that are expected to escalate the growth of the veterinary molecular diagnostics industry grow in Germany.

High usage of superior-quality diagnostics techniques and active government support are some other factors that are likely to propel the growth of the veterinary molecular diagnostics industry in Germany during the forecast period.

Increasing Demand for Smart Grids in India to Present Opportunities to the Players

The veterinary molecular diagnostics market in India is expected to accumulate a market share value of 5% in 2023. India is expected to register significant growth over the forecast period owing to the increase in the number of diagnostic laboratories, government and private funding for veterinary health care activities, and rising awareness about veterinary molecular diagnostics in the region.

In addition, the rapidly rising animal population and high adoption of veterinary diagnostic products within the country are some other factors that are anticipated to fuel the growth of the veterinary molecular diagnostics market in India over the analysis period.

Category-wise Insights

PCR Kits Segment to Take a Lead in Untiring Market

PCR Kits are estimated to account for the largest market share of 50.8% of the veterinary molecular diagnostics industry in 2023. Polymerase Chain Reaction (PCR) is widely used for molecular diagnosis in animals for the identification and detection of various pathogens. Traditional PCR techniques are rapidly being replaced by real-time PCR.

The PCR kits segment is driving the market growth, owing to factors such as the increasing need for quick result-generating tests, growing research studies for the development of new DNA and RNA-based therapies, and others.

In addition, the increasing adulteration of food products and the growing need for accurate diagnosis are some other factors that are expected to fuel the growth of the PCR Kits segment of the veterinary molecular diagnostics market in the forthcoming years.

Livestock Animals Segment to Drive the Demand for Veterinary Molecular Diagnostics Through 2033

Based on the species type, the livestock animals segment is expected to witness a significant growth of 71.0% in 2023. This growth is attributed to the rising number of companion animals across the globe. The sales are also propelled by the willingness of owners to spend more on their pets, the rising adoption of pet insurance, and the availability of cheaper and easy-to-use POC diagnostic tests for companion animals.

Moreover, infectious diseases cause a loss of production capacity in livestock animals. Therefore, governments across the globe are heavily focusing on increasing awareness about these diseases by undertaking initiatives related to diagnosis. Also, governments are working with domestic and international partners to promote animal health products. These initiatives help educate decision-makers, regulatory agencies, reference laboratories, and other end-users regarding the importance of livestock diagnosis.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Start-Up Ecosystem: How Key Players are Opening Frontiers for Future Growth?

Startups in the veterinary molecular diagnostics industry such as Basepaws, Embark Veterinary, and AnimalBiome are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and creating a larger customer base. For instance,

  • Basepaws

Basepaws is a cat genetic testing company that was established in 2018. The client must collect a sample of the cat hair and ship it to the business's laboratory for sequencing to use the service. The business examines the DNA sequence and produces a report that details the genetic composition (mix of varieties). The business utilizes genetic information to build a cross-species library of genotypic and phenotypic information that will probably be used to support translational research and comparative medicine.

  • Embark Veterinary

Embark Veterinary, which was founded in 2015, offers DNA test kits for dogs that help dog owners provide their pets with better care. More than 200,000 genetic markers are tracked by the test. Also, it offers dog owners an app via which they can schedule a visit from the Embark team and learn more about the test kit.

  • AnimalBiome

AnimalBiome is a supplier of diagnostic services based on the animal microbiome for the care of pets. Customers can send samples through an evaluation kit to extract and analyze DNA to understand the gut microbiota of their pets. They deliver an analysis report that also has a tool for comparing gut health and flags any unusual patterns in the data.

Who are the Leading Players in the Veterinary Molecular Diagnostics Market?

The veterinary molecular diagnostics industry is highly competitive, with several key players dominating the market. Companies such as IDEXX Laboratories, VCA Antech, Zoetis, and Thermo Fisher Scientific hold a significant market share and are continuously innovating to maintain their positions. Smaller players in the market are also making their mark by developing niche solutions to cater to specific veterinary needs.

One of the main challenges faced by companies in the veterinary molecular diagnostics industry is the high cost associated with developing and launching new diagnostic solutions. Additionally, strict regulations and approval processes by regulatory bodies such as the FDA and USDA can pose a challenge for companies looking to enter the market.

The Future of Veterinary Molecular Diagnostics: Exciting Investment Opportunities for New Entrants

The growing demand for molecular diagnostic solutions for pets and livestock presents a significant investment opportunity for new entrants in the market. The rise in pet ownership and increasing awareness regarding animal health has led to a surge in demand for innovative diagnostic solutions. Companies focusing on developing cost-effective, accurate, and user-friendly diagnostic tools for veterinarians can potentially carve out a niche for themselves in the market. Furthermore, strategic collaborations and partnerships with established players can help new entrants gain a foothold in the competitive landscape.

Recent Developments:       

  • In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.
  • In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.
  • In January 2021, Heska Corporation (United States) acquired Lacuna Diagnostics (United States), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.
  • In December 2020, NEOGEN Corporation (United States) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.
  • In November 2020, NEOGEN Corporation (United States) collaborated with Transnetyx Inc. (United States), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.

How Companies can Scale Their Businesses in the Veterinary Molecular Diagnostics Market?

  • Developing Innovative Products:

Businesses can increase their foothold in the market by investing in research and development to develop innovative products that can meet the growing demand for more accurate and efficient diagnostic tests. This can include developing new tests that can detect a wider range of diseases or improving existing tests to provide faster and more reliable results.

  • Forming Strategic Partnerships:

Companies can also scale their businesses by forming strategic partnerships with other companies in the industry. This can include partnering with biotech companies to develop new products or with veterinary clinics to expand their customer base.  

  • Expanding into Emerging Markets:

Companies can also scale their businesses by expanding into emerging markets where there is a growing demand for veterinary diagnostic tests. This can include countries in Asia, Latin America, and Africa where the demand for animal products is rising due to population growth and increasing urbanization. By expanding into these markets, companies can tap into new sources of revenue and gain a competitive advantage over their rivals.

  • Adopting Digital Technologies:

Businesses can also expand by adopting digital technologies such as telemedicine and remote monitoring. This can enable companies to provide more convenient and cost-effective diagnostic services to their customers, while also improving the accuracy and speed of their tests. By embracing these technologies, companies can stay ahead of the curve and position themselves as leaders in the industry.

  • Investing in Talent and Training:

Finally, companies can scale their businesses by investing in talent and training to attract and retain the best employees in the industry. This can include providing ongoing training and development opportunities to ensure that employees are up-to-date on the latest developments in the field. By investing in talent and training, companies can build a strong and skilled workforce that can help them grow and innovate in the Veterinary Molecular Diagnostics market.

Report Scope

Report Attribute Details
Growth Rate CAGR of 6.84% from 2023 to 2033
Market Value in 2022 US$ 194.47 million
Market Value in 2033 US$ 377.22 million
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product Type
  • Species Type
  • Disease Type
  • End-User
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)
Key Countries Profiled
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • bioMérieux SA
  • IDEXX Laboratories, Inc.
  • Neogen Europe, Ltd.
  • Veterinary Molecular Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.
  • ID-Vet, Qiagen N.V.

Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis

By Product Type:

  • PCR Kits
    • RT-PCR Kits
    • RAPD-PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

By Species Type:

  • Livestock Animals
    • Equine
    • Porcine
    • Poultry
    • Cattle
    • Aquatic
    • Ovine
  • Companion Animals
    • Canine
    • Feline
    • Avian

By Disease Type:

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

By End User:

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

By Region:

  • North America
  • Latin America  
  • Europe  
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

How Big is the Veterinary Molecular Diagnostics Market?

The market is valued at US$ 194.47 million in 2023.

Who are the Key Veterinary Molecular Diagnostics Market Players?

IDEXX Laboratories and Thermo Fisher Scientific Inc. are key market players.

Which is the Key Segment by Species Type?

The livestock animals segment is likely to remain preferred through 2033.

What is the Go-to-Market Strategy?

Players opt for mergers and acquisitions.

Which are the Key Asian Countries in the Veterinary Molecular Diagnostics Market?

India, Japan, and China dominate the Asian market.

Table of Content

1. Executive Summary | Veterinary Molecular Diagnostics Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. PCR Kits

            5.3.1.1. RT-PCR Kits

            5.3.1.2. RAPD-PCR Kits

        5.3.2. INAAT Kits

        5.3.3. Microarray Kits

        5.3.4. DNA Sequencing Kits

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Disease, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease, 2023 to 2033

        6.3.1. Anaplasma spp.

        6.3.2. Ehrlichia spp.

        6.3.3. New Castle Disease

        6.3.4. Influenza

        6.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Disease, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Species, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Species, 2023 to 2033

        7.3.1. Livestock Animals

            7.3.1.1. Porcine

            7.3.1.2. Poultry

            7.3.1.3. Bovine/Cattle

            7.3.1.4. Aquatic

            7.3.1.5. Ovine

        7.3.2. Companion Animals

            7.3.2.1. Canine

            7.3.2.2. Feline

            7.3.2.3. Avian

    7.4. Y-o-Y Growth Trend Analysis By Species, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Species, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Veterinary Hospitals

        8.3.2. Clinical Laboratories

        8.3.3. Veterinary Research Institutes

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. South Asia

        9.3.5. East Asia

        9.3.6. Oceania

        9.3.7. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Product

        10.2.3. By Disease

        10.2.4. By Species

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Disease

        10.3.4. By Species

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product

        11.2.3. By Disease

        11.2.4. By Species

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Disease

        11.3.4. By Species

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UNITED KINGDOM

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Product

        12.2.3. By Disease

        12.2.4. By Species

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Disease

        12.3.4. By Species

        12.3.5. By End User

    12.4. Key Takeaways

13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Rest of South Asia

        13.2.2. By Product

        13.2.3. By Disease

        13.2.4. By Species

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Disease

        13.3.4. By Species

        13.3.5. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Disease

        14.2.4. By Species

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Disease

        14.3.4. By Species

        14.3.5. By End User

    14.4. Key Takeaways

15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Product

        15.2.3. By Disease

        15.2.4. By Species

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Disease

        15.3.4. By Species

        15.3.5. By End User

    15.4. Key Takeaways

16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Product

        16.2.3. By Disease

        16.2.4. By Species

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product

        16.3.3. By Disease

        16.3.4. By Species

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Product

            17.1.2.2. By Disease

            17.1.2.3. By Species

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Product

            17.2.2.2. By Disease

            17.2.2.3. By Species

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Product

            17.3.2.2. By Disease

            17.3.2.3. By Species

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Product

            17.4.2.2. By Disease

            17.4.2.3. By Species

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Product

            17.5.2.2. By Disease

            17.5.2.3. By Species

            17.5.2.4. By End User

    17.6. UNITED KINGDOM

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Product

            17.6.2.2. By Disease

            17.6.2.3. By Species

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Product

            17.7.2.2. By Disease

            17.7.2.3. By Species

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Product

            17.8.2.2. By Disease

            17.8.2.3. By Species

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Product

            17.9.2.2. By Disease

            17.9.2.3. By Species

            17.9.2.4. By End User

    17.10. India

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Product

            17.10.2.2. By Disease

            17.10.2.3. By Species

            17.10.2.4. By End User

    17.11. Malaysia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Product

            17.11.2.2. By Disease

            17.11.2.3. By Species

            17.11.2.4. By End User

    17.12. Singapore

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Product

            17.12.2.2. By Disease

            17.12.2.3. By Species

            17.12.2.4. By End User

    17.13. Thailand

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Product

            17.13.2.2. By Disease

            17.13.2.3. By Species

            17.13.2.4. By End User

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Product

            17.14.2.2. By Disease

            17.14.2.3. By Species

            17.14.2.4. By End User

    17.15. Japan

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Product

            17.15.2.2. By Disease

            17.15.2.3. By Species

            17.15.2.4. By End User

    17.16. South Korea

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Product

            17.16.2.2. By Disease

            17.16.2.3. By Species

            17.16.2.4. By End User

    17.17. Australia

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Product

            17.17.2.2. By Disease

            17.17.2.3. By Species

            17.17.2.4. By End User

    17.18. New Zealand

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Product

            17.18.2.2. By Disease

            17.18.2.3. By Species

            17.18.2.4. By End User

    17.19. GCC Countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Product

            17.19.2.2. By Disease

            17.19.2.3. By Species

            17.19.2.4. By End User

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Product

            17.20.2.2. By Disease

            17.20.2.3. By Species

            17.20.2.4. By End User

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Product

            17.21.2.2. By Disease

            17.21.2.3. By Species

            17.21.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product

        18.3.3. By Disease

        18.3.4. By Species

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. bioMérieux SA

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. IDEXX Laboratories, Inc.

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Neogen Europe, Ltd.

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Veterinary Molecular Diagnostics, Inc.

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Thermo Fisher Scientific, Inc.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Qiagen N.V.

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Zoetis

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Heska Corp.

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Agrolabo S.p.A.

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Covetrus

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Veterinary Biologics Market

Published : January 2024

Healthcare

Veterinary Vaccines Market

Published : January 2023

Explore Healthcare Insights

View Reports

Veterinary Molecular Diagnostics Market